Full List Of Stories
London close: Stocks finish down after disappointing retail sales data
London stocks remained in the red through the afternoon to close weaker on Thursday, following the release of disappointing retail sales data, while luxury fashion brand Burberry remained in positive territory on the back of well-received interim results.
Eagle Eye makes solid progress in first four months of financial year
Real-time marketing technology company Eagle Eye Solutions Group told shareholders that its successful expansion strategy from the 2019 financial year had continued to deliver in the first four months of the current year.
Alba Mineral Resources prepares for drilling at Clogau Gold Mine
Diversified mineral exploration and development company Alba Mineral Resources announced on Thursday that its drilling contractors have mobilised to site at the Clogau Gold Mine in north Wales.
Oriole Resources makes progress at Bibemi licence
West Africa-focussed exploration company Oriole Resources updated the market on its strategy on Thursday, reporting that following its third quarter technical meetings, it had identified drill targets at the Bibemi licence in Cameroon.
Crossword launches 'Nixer CyberML' machine learning products
Cybersecurity-focussed technology commercialisation company Crossword Cybersecurity announced the launch of ‘Nixer CyberML’, a family of machine-learning based security and anti-fraud software products designed to help organisations build those capabilities into applications, on Thursday.
Time Out Group opens new market location in Montreal
Media and leisure company Time Out Group announced the opening of Time Out Market Montréal on Thursday.
Asia report: Markets finish mixed as trade negativity takes hold
Markets in Asia finished mixed on Thursday, as investors digested disappointing industrial output data from China, as well as fresh reports that Beijing and Washington had reached yet another bump in the road of trade negotiations.
Brexit stockpiling boosts Channel Tunnel traffic in October
The prospect of a hard Brexit on 31 October led to an uptick in freight traffic through the Channel Tunnel during the month, it was revealed on Thursday.
Savannah Resources upbeat on latest test work at Mina do Barroso
Resource development company Savannah Resources announced that its ongoing metallurgical test work programme was still successfully producing saleable grades of spodumene lithium concentrate with excellent recoveries at its Mina do Barroso Project in Portugal on Thursday.
Volex sees earnings surge as complex assemblies business grows
Complex assemblies and power cords producer Volex reported a 7. 3% rise in revenue in its first half results on Thursday, to $195. 7m (£152. 18m), while its underlying operating profit surged 61. 7% to $15. 9m.
Northamber revenue and earnings slip as it works to improve its fortunes
Information technology solutions provider Northamber reported a fall in revenue to £50. 33m in its preliminary results on Thursday, from £58. 14m in the prior year.
VR Education platform selected by virtual medical training app
Virtual reality technology company VR Education announced that its ‘ENGAGE’ platform has been selected by Life-saving Instruction for Emergencies (LIFE) on Thursday, which was launched at the Council of International Neonatal Nurses conference in Nairobi, Kenya.
Tracsis sees solid growth after year of acquisitions
Rail, traffic and transport technology and services provider Tracsis reported a 24% improvement in revenue in its final results on Thursday, to £49. 2m.
3i Group manages another 10pc return in first half
Private equity and venture capital company 3i Group reported “good momentum” across its portfolio in its half-year results on Thursday, with a total return of £767m, or 10% on opening shareholders' funds, compared to £728m or 10% a year earlier.
FDA accepts new drug application for AstraZeneca's selumetinib
AstraZeneca, along with its partner MSD, announced on Thursday that the US Food and Drug Administration (FDA) has accepted a new drug application (NDA) and granted ‘Priority Review’ status for selumetinib, as a potential new medicine for paediatric patients aged three years and older with neurofibromatosis type 1 and symptomatic, inoperable plexiform neurofibromas.
National Grid reports fall in interim profit, Premier Oil production at top end of forecasts
London open The FTSE 100 is expected to open six points lower on Thursday, having closed down 0. 19% at 7,351. 21 on Wednesday.
US close: Street finishes mixed as budget deficit widens
US stocks finished mixed on Wednesday, as market participants digested Federal Reserve chairman Jerome Powell's testimony to the Joint Economic Committee of Congress.